Clinical Trial Update: Impact of Ascorbic Acid in the Prevention of Vancomycin Induced Nephrotoxicty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether ascorbic acid can prevent vancomycin-induced nephrotoxicity in acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Ascorbic acid (Vitamin C)
• Vancomycin (vancomycin)

Snippet

Sponsor: Ain Shams University | Conditions: Acute Kidney Injury | Phase 4 | Status: UNKNOWN